Want A Slice Of Cutting-Edge Medical Technology? Take A Look At This ETF

Healthcare became one of the most important areas in daily life and equity markets in 2020. We previously covered several exchange-traded funds in the industry, such as the Health Care Select Sector SPDR® Fund (NYSE:XLV) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Today we extend the discussion to ETFs that focus on highlights:

"genomic medicine is making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease."

Scientists across the globe sequencing .

With that information, here is a fund that may pique investors' interest.

ARK Genomic Revolution ETF/h2

• Current Price: $104.73
• 52-Week Range: $24.00 - $114.83
• Dividend Yield: N/A
• Expense Ratio: 0.75%

The ARK Genomic Revolution ETF (NYSE:ARKG) provides access to businesses that are part of the scientific developments and advancements in genomics. They might focus on:

has “a proprietary technology that pioneers a new method of manufacturing synthetic DNA,” Pacific Biosciences of California (NASDAQ:PACB) which produces DNA sequencing technology, molecular diagnostics company Exact Sciences (NASDAQ:EXAS) and biotechnology group Regeneron Pharmaceuticals (NASDAQ:REGN) lead the names in the roster.

Over the past year, ARKG has returned over 216% and hit a record-high in late January. In fact, year-to-date (YTD), it is already up over 10%. Given the recent run-up in price, there is likely to be some profit-taking in the fund in the coming weeks.

Yet we can expect many of the names in the fund to continue to grow, possibly in double digits. A potential decline of 5%-7% from the current price level would improve the margin of safety for buy-and-hold investors.

Bottom Line/h2

Genomics will likely continue to impact our lives in the new decade. Thus, we can expect Wall Street to continue focus on this important field and offer new funds. In addition to ARKG, there are other ETFs that could be of interest to readers. They include:

• Franklin Genomic Advancements ETF (NYSE:HELX) - up 9.36% YTD;
• Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - up 5.97% YTD;
• iShares Genomics Immunology and Healthcare ETF (NYSE:IDNA) - up 11.14% YTD.

We plan to cover these funds in the coming weeks.

Get The News You Want

Read market moving news with a personalized feed of stocks you care about.

Get The App

Written By: Investing.com